ado thoughts

Size of this deal alone isnt the price driver

Each signing that comes increases the chances of more companies signing

*This will be valued on a very highly on the massive growth pipelines the company has.

*This deal alone gives mixngo global exposure to many end users worldwide.

*Short term PE ratios are irrelevant as investors are paying for an assumption of what % of companys they think will sign

*Even as a worse case assume we are at break even with no need for further dillution - How many companies can say that?

*762,000,000 shares on issue

* Annual burn $2-3m

*Anteo deal in licensing of their patented technology MixnGo which has granted patents in Europe, Australia and patent pending in the US (Soon to be granted)

* In commercial discussions with nearly all major IVD companies - This market annually is worth $10B

*Royaltys expected 2-5% of sales for larger players and around 10% for smaller ones.

* A break even or cashflow positive position puts us in a happy place when it comes to other negotiations - If they know we are not going to run out of money we have better bargaining power.

* Unlike many companies Anteo Diagnostics are not a one trick pony - Our patents are so broad and cover a couple of thousand different surfaces

* If you have just come across this stock today for the first time I highly recommend you spend time researching its potential.

Posters may ramp up or down this announcemnt but facts are cash will be hitting the bank and IMO some nice surprises to come throughout the year

Twinvest